John A. Boockvar
John A. Boockvar (b ca 1971)[1] is a neurosurgeon. He is Vice Chair of the Department of Neurosurgery at Lenox Hill Hospital, professor of neurosurgery and otolaryngology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He also heads the neuro-oncology research program at the Feinstein Institute for Medical Research.[2]
Boockvar earned his undergraduate degree at University of Pennsylvania. He earned his medical degree from the SUNY Downstate Medical Center, as did his father, grandfather, and great-grandfather. He did his residency and a post-doc at the University of Pennsylvania School of Medicine.[2] Prior to joining the Northwell in 2014, Boockvar was a professor of neurosurgery and neuroscience as well as the co-director of the brain and spine tumor program at the Weill Cornell Medical College and a neurosurgeon at New York Presbyterian Hospital.[1]
While at Cornell, he led a clinical trial in which Avastin and a blood brain barrier-disrupting agent were delivered to the brain via a catheter inserted through an artery, as a way to get the monoclonal antibody drug into glioblastoma tumors.[3][4] As of 2016, this was one of several similar methods under development to try to improve the treatment of brain tumors and to reduce adverse effects.[5] He has also done basic research studying cancer stem cells in the context of brain tumors, as well as methods to use neural stem cells to treat brain disorders.[6] He has publicly advocated for stem cell research.[7][8]
Starting when he was at Cornell, he has convened an annual meeting bringing together doctors and people from the biotech industry who are working to develop better ways to treat brain tumors.[9] In 2014 the Feinstein Institute opened a research center, of which Boockvar is the co-director, aimed at helping startup companies test ideas to treat or diagnose brain tumors.[10]
References[edit]
- ↑ 1.0 1.1 "John Boockvar - North Shore-LIJ Health System - Executive Moves". Crain's New York Business. Retrieved 12 June 2018.
- ↑ 2.0 2.1 "John A. Boockvar, MD". The Feinstein Institute for Medical Research. Retrieved 12 April 2018.
- ↑ Grady, Denise (November 16, 2009). "Breaching the Blood-Brain Barrier With Avastin to Fight Glioblastoma".
- ↑ Burkhardt, JK; Riina, HA; Shin, BJ; Moliterno, JA; Hofstetter, CP; Boockvar, JA (September 2011). "Intra-arterial chemotherapy for malignant gliomas: a critical analysis". Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 17 (3): 286–95. doi:10.1177/159101991101700302. PMC 3396041. PMID 22005689.
- ↑ Su, YS; Ali, R; Feroze, AH; Li, G; Lawton, MT; Choudhri, O (April 2016). "Endovascular therapies for malignant gliomas: Challenges and the future". Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 26: 26–32. doi:10.1016/j.jocn.2015.10.019. PMID 26857294.
- ↑ "John Boockvar profile". NYSTEM. Retrieved 12 June 2018.
- ↑ "Emotive power of US stem cell debate". BBC. 25 May 2005.
- ↑ Salter, Jim (25 October 2006). "Actors, Athletes to Be in Stem-Cell Ad". Washington Post.
- ↑ Schneider, Julia R; et al. (8 June 2018). "Commentary: Advances in Glioblastoma Therapies: A Collaborative Effort Between Physicians and the Biotechnology Industry". Neurosurgery. doi:10.1093/neuros/nyy253.
- ↑ Zeller, Gregory (9 August 2015). "Debrief: John Boockvar, Feinstein Institute - Innovate Long Island". Innovate Long Island.
This article "John A. Boockvar" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:John A. Boockvar. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
